Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,738 | 375 | 99.8% |
| Education | $9.39 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $769.42 | 37 | $0 (2022) |
| Novo Nordisk Inc | $673.32 | 42 | $0 (2022) |
| PFIZER INC. | $487.50 | 46 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $441.91 | 28 | $0 (2021) |
| ABBVIE INC. | $413.14 | 24 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $284.77 | 18 | $0 (2020) |
| Allergan, Inc. | $274.62 | 26 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $258.54 | 20 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $231.55 | 18 | $0 (2022) |
| Astellas Pharma US Inc | $224.03 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $497.49 | 28 | ABBVIE INC. ($157.20) |
| 2021 | $1,279 | 65 | Amgen Inc. ($237.47) |
| 2020 | $313.66 | 22 | Novo Nordisk Inc ($64.56) |
| 2019 | $1,220 | 87 | Novo Nordisk Inc ($299.43) |
| 2018 | $1,229 | 77 | Amgen Inc. ($300.56) |
| 2017 | $1,208 | 98 | PFIZER INC. ($175.67) |
All Payment Transactions
377 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/10/2022 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: IMMUNOLOGY | ||||||
| 03/30/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLUJAN | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: PRIMARY CARE | ||||||
| 03/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Diabetes Care | ||||||
| 03/09/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $19.36 | General |
| Category: Cardiovascular | ||||||
| 03/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Diabetes | ||||||
| 03/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Gastroenterology | ||||||
| 02/24/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Inflammation | ||||||
| 02/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: PRIMARY CARE | ||||||
| 02/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardio-renal | ||||||
| 01/31/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/27/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), VERQUVO, STEGLATRO | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes | ||||||
| 01/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
| 01/20/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 713 | 725 | $61,516 | $30,550 |
| 2021 | 15 | 2,948 | 3,431 | $277,303 | $179,645 |
| 2020 | 18 | 3,021 | 3,596 | $286,063 | $153,413 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 117 | 117 | $19,305 | $14,475 | 75.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 112 | 112 | $20,384 | $7,608 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 103 | $13,596 | $3,823 | 28.1% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 120 | 120 | $2,640 | $2,072 | 78.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 112 | 112 | $2,464 | $1,901 | 77.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 124 | 132 | $2,112 | $393.00 | 18.6% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2022 | 29 | 29 | $1,015 | $277.58 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 447 | 447 | $73,755 | $55,383 | 75.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 444 | 445 | $80,990 | $49,966 | 61.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 315 | 519 | $68,508 | $42,159 | 61.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 416 | 416 | $9,152 | $7,080 | 77.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 405 | 405 | $8,910 | $6,893 | 77.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 82 | 83 | $6,045 | $5,410 | 89.5% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 81 | 81 | $3,240 | $2,905 | 89.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 17 | 17 | $3,332 | $2,673 | 80.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 458 | 688 | $11,008 | $2,054 | 18.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 81 | 82 | $1,886 | $1,252 | 66.4% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 34 | 34 | $1,360 | $1,220 | 89.7% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2021 | 91 | 120 | $4,200 | $1,157 | 27.6% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 49 | 54 | $3,402 | $1,099 | 32.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 25 | $975.00 | $240.81 | 24.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 15 | 15 | $540.00 | $152.60 | 28.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 455 | 455 | $71,610 | $49,180 | 68.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 369 | 650 | $85,800 | $39,641 | 46.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 351 | 354 | $62,636 | $34,048 | 54.4% |
About Dr. Albert Steele, M.D
Dr. Albert Steele, M.D is a Internal Medicine healthcare provider based in Madison, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588771455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Steele, M.D has received a total of $5,747 in payments from pharmaceutical and medical device companies, with $497.49 received in 2022. These payments were reported across 377 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,738).
As a Medicare-enrolled provider, Steele has provided services to 6,682 Medicare beneficiaries, totaling 7,752 services with total Medicare billing of $363,608. Data is available for 3 years (2020–2022), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Madison, MS
- Active Since 08/24/2006
- Last Updated 08/20/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588771455
Products in Payments
- Repatha (Biological) $456.86
- Ozempic (Drug) $399.10
- FARXIGA (Drug) $302.37
- LYRICA (Drug) $184.49
- XARELTO (Drug) $179.29
- VRAYLAR (Drug) $171.61
- XIFAXAN (Drug) $162.31
- JARDIANCE (Drug) $146.17
- EVENITY (Biological) $142.98
- TRADJENTA (Drug) $139.05
- NEXLIZET (Drug) $125.00
- SOLIQUA (Drug) $123.58
- TOUJEO (Drug) $122.01
- LINZESS (Drug) $119.90
- TRELEGY ELLIPTA (Drug) $119.29
- QULIPTA (Drug) $106.35
- Prolia (Biological) $105.22
- CHANTIX (Drug) $97.58
- UBRELVY (Drug) $95.59
- Myrbetriq (Drug) $95.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Madison
Arthur Decillis, M.d, M.D
Internal Medicine — Payments: $887,994
Dr. Jeremy Taylor, M.d, M.D
Internal Medicine — Payments: $181,774
Darrell Arnett, Md, MD
Internal Medicine — Payments: $65,659
Karyn Baum, M.d, M.D
Internal Medicine — Payments: $59,996
Sara Mccoy, Md, MD
Internal Medicine — Payments: $53,924
John Ferguson, Md, MD
Internal Medicine — Payments: $48,742